Literature DB >> 23089891

Left ventricular apical aneurysm following primary percutaneous coronary intervention.

Masayuki Mori1, Kenichi Sakakura, Hiroshi Wada, Nahoko Ikeda, Hiroyuki Jinnouchi, Yoshitaka Sugawara, Norifumi Kubo, Shin-ichi Momomura, Junya Ako.   

Abstract

Left ventricular apical aneurysm (LVAA) is a serious complication of acute anterior myocardial infarction (MI). The purpose of our study was to investigate the clinical features of LVAA in the primary PCI era. A total of 161 acute anterior MI patients who had primary PCI and had an echocardiogram on chronic phase were included. The development of LVAA was reviewed on chronic phase. Univariate and multivariate logistic regression analyses were performed to identify the predictors of LVAA. Primary stenting was performed in 160 patients (99.4 %). Procedural success was obtained in all patients with a final TIMI flow grade 3 obtained in 142 patients (88.2 %). LVAA developed in the chronic phase in 29 patients (18.0 %). Multivariate logistic regression analysis revealed that peak CK (500 mU/ml increase; OR 1.24, 95 % CI 1.09-1.41, p = 0.001), heart rate at discharge (5/min increase; OR 1.39, 95 % CI 1.03-1.87, p = 0.03), final TIMI flow grade ≤2 (vs. TIMI 3; OR 6.95, 95 % CI 1.70-28.36, p = 0.01) and final myocardial brush grade (MBG) ≤2 (vs. MBG 3; OR 4.33, 95 % CI 1.06-17.66, p = 0.04) were significantly associated with the development of LVAA. The initial TIMI flow grade or the grade of collateral flow was not associated with LVAA. In conclusion, peak CK, heart rate, and final TIMI flow grade or final MBG ≤2 were significantly associated with the development of LVAA. Achieving a TIMI flow grade 3 by primary PCI may be important for preventing LVAA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089891     DOI: 10.1007/s00380-012-0301-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

Review 1.  Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.

Authors:  Marc Cohen
Journal:  Catheter Cardiovasc Interv       Date:  2009-10-01       Impact factor: 2.692

2.  Left ventricular aneurysm and prognosis in patients with first acute transmural anterior myocardial infarction and isolated left anterior descending artery disease.

Authors:  W F Shen; C Tribouilloy; A Mirode; H Dufossé; J P Lesbre
Journal:  Eur Heart J       Date:  1992-01       Impact factor: 29.983

3.  Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction.

Authors:  Gregg W Stone; Michael A Peterson; Alexandra J Lansky; George Dangas; Roxana Mehran; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

4.  Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction.

Authors:  Sorin J Brener; Ecaterina Cristea; Alexandra J Lansky; Martin Fahy; Roxana Mehran; Gregg W Stone
Journal:  Circ Cardiovasc Interv       Date:  2012-07-24       Impact factor: 6.546

5.  Does left ventricular aneurysm influence survival after acute myocardial infarction?

Authors:  M Heras; G Sanz; A Betriu; L Mont; T de Flores; F Navarro-López
Journal:  Eur Heart J       Date:  1990-05       Impact factor: 29.983

6.  Determinants of left ventricular aneurysm formation after anterior myocardial infarction: a clinical and angiographic study.

Authors:  M B Forman; H W Collins; H A Kopelman; W K Vaughn; J M Perry; R Virmani; G C Friesinger
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

7.  Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.

Authors:  Daniel H Berrocal; Mauricio G Cohen; Alejandro D Spinetta; Marta García Ben; Carlos A Rojas Matas; José M Gabay; José M Magni; Gustavo Nogareda; Pablo Oberti; Cristian Von Schulz; Hernán Doval; Oscar O Bazzino; Arturo Cagide; Raul Oliveri; Liliana R Grinfeld
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

8.  Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction.

Authors:  Rajendra H Mehta; Immad Sadiq; Robert J Goldberg; Joel M Gore; Alvaro Avezum; Frederick Spencer; Eva Kline-Rogers; Jeanna Allegrone; Karen Pieper; Keith A A Fox; Kim A Eagle
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

Review 9.  Left ventricular mural thrombus.

Authors:  J V Nixon
Journal:  Arch Intern Med       Date:  1983-08

10.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

Authors:  A W van 't Hof; A Liem; H Suryapranata; J C Hoorntje; M J de Boer; F Zijlstra
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

View more
  3 in total

1.  Transient no reflow following primary percutaneous coronary intervention.

Authors:  Hiroyuki Jinnouchi; Kenichi Sakakura; Hiroshi Wada; Kenshiro Arao; Norifumi Kubo; Yoshitaka Sugawara; Hiroshi Funayama; Shin-ichi Momomura; Junya Ako
Journal:  Heart Vessels       Date:  2013-06-27       Impact factor: 2.037

2.  Predictors and long-term prognosis of left ventricular aneurysm in patients with acute anterior myocardial infarction treated with primary percutaneous coronary intervention in the contemporary era.

Authors:  Jieyun You; Liming Gao; Yunli Shen; Wei Guo; Xingxu Wang; Qing Wan; Xiaoyan Wang; Jian Wu; Qi Zhang
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 3.005

3.  Novel Analysis of Coronary Angiography in Predicting the Formation of Ventricular Aneurysm in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention.

Authors:  Pujiao Yu; Peng Xi; Yu Tang; Jiahong Xu; Yang Liu
Journal:  Front Cardiovasc Med       Date:  2022-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.